# Biotech Daily Digest ‚Äî 2025-10-06

**36 items from 4 sources**

## Summary by Source

- Endpoints News: 7 items
- Fierce Biotech: 5 items
- MHRA ‚Äì News: 1 item
- arXiv q-bio: 23 items


## Endpoints News

- **[NanoPhoria‚Äôs ‚Ç¨83M Series A; AstraZeneca makes deal worth up to $555M with Algen](https://endpoints.news/nanophorias-e83m-series-a-astrazeneca-makes-deal-worth-up-to-555m-with-algen/)**  
  _Mon, 06 Oct 2025 14:29:40 +0000_  
  Plus, news about Arvinas, Alnylam, Sihuan Pharmaceutical, Neurizon Therapeutics, Nordicus Partners, and Arcutis:

 ü´Ä NanoPhoria raises $98M Series A: The cash will fund early clinical development of the Milan-based company‚Äôs heart failure candidate, known as ...

- **[Keeping it simple: Chen Yu steers into round three with $1.3B biotech fund](https://endpoints.news/keeping-it-simple-chen-yu-steers-into-round-three-with-1-3b-biotech-fund/)**  
  _Mon, 06 Oct 2025 12:00:53 +0000_  
  When Chen Yu unveiled the first round for his new, $800 million-plus venture fund back in the heyday of the 2021 pandemic boom, IPOs were all the rage and he styled it as a crossover ...

- **[Cell therapy CDMO Mytos unveils its first facility in the UK](https://endpoints.news/cell-therapy-cdmo-mytos-unveils-its-first-facility-in-the-uk/)**  
  _Mon, 06 Oct 2025 12:00:45 +0000_  
  UK-headquartered cell therapy manufacturer Mytos is launching its first CDMO facility in the country, with plans to establish another facility elsewhere in the next four years.



 ‚ÄúWhat's great about automated manufacturing is that it's very ...

- **[Metsera got less than it wanted from Pfizer in long-awaited obesity biotech acquisition](https://endpoints.news/metsera-got-less-than-it-wanted-from-pfizer-in-long-awaited-obesity-biotech-acquisition/)**  
  _Mon, 06 Oct 2025 11:41:42 +0000_  
  Pfizer wasn‚Äôt the only pharma interested in buying Metsera, and it also didn‚Äôt pay as much as the obesity biotech‚Äôs board desired, according to new regulatory documents outlining their $4.9 billion M&A deal ...

- **[Arbor partners with Chiesi Group in gene editing deal](https://endpoints.news/arbor-partners-with-chiesi-group-in-gene-editing-deal/)**  
  _Mon, 06 Oct 2025 11:00:11 +0000_  
  Chiesi Group is getting into CRISPR. The Italian drugmaker on Monday announced a deal with Arbor Biotechnologies to license and develop its gene editing therapy for a rare condition called primary hyperoxaluria type 1  ...

- **[AstraZeneca, Daiichi Sankyo report Phase 3 win for Datroway in triple negative breast cancer](https://endpoints.news/astrazeneca-daiichi-sankyo-report-phase-3-win-for-datroway-in-triple-negative-breast-cancer/)**  
  _Mon, 06 Oct 2025 10:14:51 +0000_  
  AstraZeneca and Daiichi Sankyo‚Äôs successor to their blockbuster drug Enhertu has cleared the first of several registrational studies in triple-negative breast cancer that could position it for a key label expansion.

 Datroway, also known as ...

- **[Trogenix raises $95M Series A as brain cancer program nears clinic](https://endpoints.news/trogenix-raises-95m-series-a-as-brain-cancer-therapy-candidate-nears-clinic/)**  
  _Sun, 05 Oct 2025 23:01:22 +0000_  
  Less than a year after leaving stealth mode, Trogenix has raised $95 million in a Series A round aimed at advancing its ‚ÄúTrojan horse‚Äù approach to treating cancer, starting with its lead program for glioblastoma ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/medtech/icecure-medical-stock-jumps-fda-gives-green-light-breast-cancer-cryoablation-treatment" hreflang="en">IceCure Medical stock jumps as FDA greenlights breast cancer cryoablation treatment</a>](https://www.fiercebiotech.com/medtech/icecure-medical-stock-jumps-fda-gives-green-light-breast-cancer-cryoablation-treatment)**  
  _Oct 6, 2025 2:45am_  
  IceCure Medical‚Äôs tumor-freezing treatment ProSense has nabbed FDA approval, making it the first medical device of its kind to be marketed for the local treatment of breast cancer.

- **[<a href="https://www.fiercebiotech.com/medtech/foundation-medicine-looks-boost-cancer-biomarker-tests-black-latinx-and-lgbtq-community" hreflang="en">Foundation Medicine looks to boost cancer biomarker testing in Black, Latinx and LGBTQ+ communities</a>](https://www.fiercebiotech.com/medtech/foundation-medicine-looks-boost-cancer-biomarker-tests-black-latinx-and-lgbtq-community)**  
  _Oct 4, 2025 3:47am_  
  Foundation Medicine has a big IDEA‚ÄîImproving Diagnostics Education and Awareness‚Äîand now it's handing out a new grant attached to the program.

- **[<a href="https://www.fiercebiotech.com/biotech/astrazeneca-algen-biotechnolgies-pen-555m-ai-pact-immunology-targets" hreflang="en">AstraZeneca, Algen Biotechnologies pen $555M AI pact for immunology targets</a>](https://www.fiercebiotech.com/biotech/astrazeneca-algen-biotechnolgies-pen-555m-ai-pact-immunology-targets)**  
  _Oct 6, 2025 7:07am_  
  AstraZeneca has signed a $555 million deal with San Francisco biotech Algen Biotechnologies that will tap the latter company‚Äôs artificial intelligence platform to boost discovery of new targets in immunology.

- **[<a href="https://www.fiercebiotech.com/biotech/skyes-shares-crater-cb1-blocker-fails-reduce-weight-phase-2-obesity-study" hreflang="en">Skye's shares crater as CB1 blocker fails to reduce weight in phase 2 obesity study</a>](https://www.fiercebiotech.com/biotech/skyes-shares-crater-cb1-blocker-fails-reduce-weight-phase-2-obesity-study)**  
  _Oct 6, 2025 7:18am_  
  Skye Bioscience‚Äôs obesity candidate has failed to reduce weight in a phase 2 study, marking another setback for the CB1 inhibitor class.

- **[<a href="https://www.fiercebiotech.com/biotech/4-reasons-why-life-sciences-still-fails-women-top-despite-female-majority-workforce-report" hreflang="en">4 reasons life sciences still fail women at the top, despite a female-majority workforce: report</a>](https://www.fiercebiotech.com/biotech/4-reasons-why-life-sciences-still-fails-women-top-despite-female-majority-workforce-report)**  
  _Oct 3, 2025 10:56am_  
  Biopharma is set to lose two of the industry‚Äôs rare women CEOs‚ÄîGSK‚Äôs Emma Walmsley and Merck KGaA's Bel√©n Garijo‚Äîleaving a dearth of women-helmed large life sciences companies.


## MHRA ‚Äì News

- **[BD BodyComm‚Ñ¢ version 3.3 software used for BodyGuard infusion pumps, BodyGuard-T and T34 syringe drivers: Important steps to manage transition to Windows 11 (DSI/2025/006)](https://www.gov.uk/drug-device-alerts/bd-bodycomm-version-3-dot-3-software-used-for-bodyguard-infusion-pumps-bodyguard-t-and-t34-syringe-drivers-important-steps-to-manage-transition-to-windows-11-dsi-slash-2025-slash-006)**  
  _2025-10-06T13:03:14Z_  
  The BodyComm software currently uses Windows 10. Microsoft is transitioning to Windows 11 from 14 October 2025 which requires an updated cable to connect the pumps to the BodyComm software. These cables may not be available until after the Windows transition date.


## arXiv q-bio

- **[Glaucoma Detection and Structured OCT Report Generation via a Fine-tuned Multimodal Large Language Model](https://arxiv.org/abs/2510.02403)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02403v1 Announce Type: new 
Abstract: Objective: To develop an explainable multimodal large language model (MM-LLM) that (1) screens optic nerve head (ONH) OCT circle scans for quality and (2) generates structured clinical reports that include glaucoma diagnosis and sector-wise retinal nerve fiber layer (RN‚Ä¶

- **[Cross-Platform DNA Methylation Classifier for the Eight Molecular Subtypes of Group 3 & 4 Medulloblastoma](https://arxiv.org/abs/2510.02416)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02416v1 Announce Type: new 
Abstract: Medulloblastoma is a malignant pediatric brain cancer, and the discovery of molecular subgroups is enabling personalized treatment strategies. In 2019, a consensus identified eight novel subtypes within Groups 3 and 4, each displaying heterogeneous characteristics. Clas‚Ä¶

- **[Head and Eye Control in Persons with Low Vision during Urban Navigation](https://arxiv.org/abs/2510.02533)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02533v1 Announce Type: new 
Abstract: Low vision involves a range of visual impairments that significantly impact daily activities, particularly navigation in urban environments. Individuals with low vision often develop adaptive strategies to compensate for visual deficits, relying on head movements to bri‚Ä¶

- **[FLOWR.root: A flow matching based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction](https://arxiv.org/abs/2510.02578)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02578v1 Announce Type: new 
Abstract: We present Flowr.root, an equivariant flow-matching model for pocket-aware 3D ligand generation with joint binding affinity prediction and confidence estimation. The model supports de novo generation, pharmacophore-conditional sampling, fragment elaboration, and multi-e‚Ä¶

- **[Accurate linear modeling of EEG-based cortical activity during a passive motor task with input: a sub-space identification approach](https://arxiv.org/abs/2510.02596)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02596v1 Announce Type: new 
Abstract: This paper studies linear mathematical modeling of brain's cortical dynamics using electroencephalography (EEG) data in an experiment with continuous exogenous input. The EEG data were recorded while participants were seated with their wrist strapped to a haptic manipul‚Ä¶

- **[SAE-RNA: A Sparse Autoencoder Model for Interpreting RNA Language Model Representations](https://arxiv.org/abs/2510.02734)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02734v1 Announce Type: new 
Abstract: Deep learning, particularly with the advancement of Large Language Models, has transformed biomolecular modeling, with protein advances (e.g., ESM) inspiring emerging RNA language models such as RiNALMo. Yet how and what these RNA Language Models internally encode about‚Ä¶

- **[Dynamics of memory B cells and plasmablasts in healthy individuals](https://arxiv.org/abs/2510.02812)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02812v1 Announce Type: new 
Abstract: Our adaptive immune system relies on the persistence over long times of a diverse set of antigen-experienced B cells to encode our memories of past infections and to protect us against future ones. While longitudinal repertoire sequencing promises to track the long-term‚Ä¶

- **[Pyk2 plays a critical role in synaptic dysfunction during the early stages of Alzheimer's disease](https://arxiv.org/abs/2510.02824)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02824v1 Announce Type: new 
Abstract: Background: The locus of the gene PTK2B encoding the tyrosine kinase Pyk2 has been associated with the risk of late-onset Alzheimer's disease, the predominant form of dementia. Pyk2 is primarily expressed in neurons where it is involved in excitatory neurotransmission a‚Ä¶

- **[The land use-climate change-biodiversity nexus in European islands stakeholders](https://arxiv.org/abs/2510.02829)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02829v1 Announce Type: new 
Abstract: To promote climate adaptation and mitigation, it is crucial to understand stakeholder perspectives and knowledge gaps on land use and climate changes. Stakeholders across 21 European islands were consulted on climate and land use change issues affecting ecosystem servic‚Ä¶

- **[The Principle of Isomorphism: A Theory of Population Activity in Grid Cells and Beyond](https://arxiv.org/abs/2510.02853)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02853v1 Announce Type: new 
Abstract: Identifying the principles that determine neural population activity is paramount in the field of neuroscience. We propose the Principle of Isomorphism (PIso): population activity preserves the essential mathematical structures of the tasks it supports. Using grid cells‚Ä¶

- **[Selective disruption of reach-related saccade timing following a middle-cerebral artery stroke](https://arxiv.org/abs/2510.03076)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.03076v1 Announce Type: new 
Abstract: Background: Coordinated control of eye and hand movements is critical for nearly all goal-directed actions, underpinning tasks ranging from simple object manipulation to complex tool use. This coordination relies on temporal coupling between reach and saccade. Stroke di‚Ä¶

- **[Stimulus-Voltage-Based Prediction of Action Potential Onset Timing: Classical vs. Quantum-Inspired Approaches](https://arxiv.org/abs/2510.03155)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.03155v1 Announce Type: new 
Abstract: Accurate modeling of neuronal action potential (AP) onset timing is crucial for understanding neural coding of danger signals. Traditional leaky integrate-and-fire (LIF) models, while widely used, exhibit high relative error in predicting AP onset latency, especially un‚Ä¶

- **[Uncertainty-Guided Model Selection for Tabular Foundation Models in Biomolecule Efficacy Prediction](https://arxiv.org/abs/2510.02476)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02476v1 Announce Type: cross 
Abstract: In-context learners like TabPFN are promising for biomolecule efficacy prediction, where established molecular feature sets and relevant experimental results can serve as powerful contextual examples. However, their performance is highly sensitive to the provided cont‚Ä¶

- **[Surface Acoustic Wave Hemolysis Assay for Evaluating Stored Red Blood Cells](https://arxiv.org/abs/2510.02482)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02482v1 Announce Type: cross 
Abstract: Blood transfusion remains a cornerstone of modern medicine, saving countless lives daily. Yet the quality of transfused blood varies dramatically among donors-a critical factor often overlooked in clinical practice. Rapid, benchtop, and cost-effective methods for eval‚Ä¶

- **[Mean-field analysis of a neural network with stochastic STDP](https://arxiv.org/abs/2510.02545)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02545v1 Announce Type: cross 
Abstract: Analysing biological spiking neural network models with synaptic plasticity has proven to be challenging both theoretically and numerically. In a network with N all-to-all connected neurons, the number of synaptic connections is on the order of $N^2$, making these mod‚Ä¶

- **[Identifying Asymptomatic Nodes in Network Epidemics using Graph Neural Networks](https://arxiv.org/abs/2510.02568)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02568v1 Announce Type: cross 
Abstract: Infected individuals in some epidemics can remain asymptomatic while still carrying and transmitting the infection. These individuals contribute to the spread of the epidemic and pose a significant challenge to public health policies. Identifying asymptomatic individu‚Ä¶

- **[Learning Explicit Single-Cell Dynamics Using ODE Representations](https://arxiv.org/abs/2510.02903)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02903v1 Announce Type: cross 
Abstract: Modeling the dynamics of cellular differentiation is fundamental to advancing the understanding and treatment of diseases associated with this process, such as cancer. With the rapid growth of single-cell datasets, this has also become a particularly promising and act‚Ä¶

- **[Towards Electrophysiological and Histological Mapping of Upper Limb Nerves in Pigs Using Epineural Stimulation](https://arxiv.org/abs/2510.02979)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2510.02979v1 Announce Type: cross 
Abstract: Understanding the relationship between nerve anatomy and the functional outcomes of electrical stimulation is critical for optimizing neural interface design. In this study, we conducted acute experiments on four pigs in which epineural cuff electrodes with multiple c‚Ä¶

- **[On diffusion posterior sampling via sequential Monte Carlo for zero-shot scaffolding of protein motifs](https://arxiv.org/abs/2412.05788)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2412.05788v2 Announce Type: replace 
Abstract: With the advent of diffusion models, new proteins can be generated at an unprecedented rate. The motif scaffolding problem requires steering this generative process to yield proteins with a desirable functional substructure called a motif. While models have been tra‚Ä¶

- **[Stochastic Mutation as a Mechanism for the Emergence of SARS-CoV-2 New Variants](https://arxiv.org/abs/2502.10471)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2502.10471v3 Announce Type: replace 
Abstract: Predicting the future evolutionary trajectory of SARS-CoV-2 remains a critical challenge, particularly due to the pivotal role of spike protein mutations. It is therefore essential to develop evolutionary models capable of continuously integrating new experimental d‚Ä¶

- **[DeepGDel: Deep Learning-based Gene Deletion Prediction Framework for Growth-Coupled Production in Genome-Scale Metabolic Models](https://arxiv.org/abs/2504.06316)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2504.06316v5 Announce Type: replace 
Abstract: In genome-scale constraint-based metabolic models, gene deletion strategies are crucial for achieving growth-coupled production, where cell growth and target metabolite production are simultaneously achieved. While computational methods for calculating gene deletion‚Ä¶

- **[Impact of SMILES Notational Inconsistencies on Chemical Language Models Trained via Molecular Translation](https://arxiv.org/abs/2505.07139)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2505.07139v3 Announce Type: replace 
Abstract: Chemical language models (CLMs) are increasingly used for molecular modeling, yet their reliability is undermined by inconsistencies in the SMILES notation. Even canonical SMILES differ across toolkits, and stereochemical annotations are frequently incomplete, but t‚Ä¶

- **[phylo2vec: a library for vector-based phylogenetic tree manipulation](https://arxiv.org/abs/2506.19490)**  
  _Mon, 06 Oct 2025 00:00:00 -0400_  
  arXiv:2506.19490v2 Announce Type: replace 
Abstract: Phylogenetics is a fundamental component of evolutionary analysis frameworks in biology and linguistics. Recently, the advent of large-scale genomics and the SARS-CoV-2 pandemic has highlighted the necessity for phylogenetic software to handle large datasets. While‚Ä¶
